Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015850939> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W3015850939 endingPage "243" @default.
- W3015850939 startingPage "237" @default.
- W3015850939 abstract "The medicament afamelanotide is an analogue of endogenous ?-melanocyte-stimulating hormone. It promotes cutaneous pigmentation, providing protection from sunlight. In dermatology, afamelanotide seems to establish therapeutic results for polymorphic light eruption, solar urticaria, erythropoietic protoporphyria, Hailey-Hailey disease, vitiligo and acne vulgaris. Afamelanotide is available for non-medical use to realise quick and easy skin tanning. Adverse effects of afamelanotide mentioned in the scientific literature are development and aggravation of melanocytic naevi, degeneration of melanocytic naevi to melanomas, melanonychia, systemic toxicity, rhabdomyolysis, posterior reversible encephalopathy syndrome, priapism and hyperpigmentation of oral soft tissues. Furthermore, numerous adverse effects of afamelanotide have been reported to the Netherlands pharmacovigilance centre LAREB as well as numerous adverse effects due to overdosage of afamelanotide to the National Poisons Information Centre. Dentists should be alert to hyperpigmentation of oral soft tissues due to afamelanotide.Het medicament afamelanotide is een analoog van ?-melanocytstimulerend hormoon. Het bevordert de pigmentatie van de huid en biedt daardoor bescherming tegen zonlicht. In de dermatologie lijkt afamelanotide heilzaam bij polymorfe lichteruptie, zonne-urticaria, erytropoëtische protoporfyrie, de ziekte van Hailey-Hailey, vitiligo en acne vulgaris. Voor niet-medicinale toepassing is afamelanotide verkrijgbaar voor het snel en eenvoudig bruinen van de huid. In de wetenschappelijke literatuur is als bijwerking van afamelanotide melding gemaakt van ontwikkeling en verergering van melanocytaire naevi, ontaarding van melanocytaire naevi in melanomen, melanonychia, systemische intoxicatie, rabdomyolyse, posterieur reversibel encefalopathiesyndroom, priapisme en hyperpigmentatie van orale slijmvliezen. Daarnaast zijn tal van bijwerkingen gemeld bij het Bijwerkingencentrum LAREB en tal van bijwerkingen bij overdosering van afamelanotide bij het Nationaal Vergiftigingen Informatie Centrum. Tandartsen moeten attent zijn op hyperpigmentatie van de orale slijmvliezen door afamelanotide." @default.
- W3015850939 created "2020-04-17" @default.
- W3015850939 creator A5001554332 @default.
- W3015850939 creator A5044570667 @default.
- W3015850939 creator A5049205349 @default.
- W3015850939 creator A5049923724 @default.
- W3015850939 creator A5057389827 @default.
- W3015850939 creator A5070298664 @default.
- W3015850939 date "2020-04-03" @default.
- W3015850939 modified "2023-09-30" @default.
- W3015850939 title "Medicaments and oral healthcare. Hyperpigmentation of oral soft tissues due to afamelanotide" @default.
- W3015850939 doi "https://doi.org/10.5177/ntvt.2020.04.19115" @default.
- W3015850939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32459219" @default.
- W3015850939 hasPublicationYear "2020" @default.
- W3015850939 type Work @default.
- W3015850939 sameAs 3015850939 @default.
- W3015850939 citedByCount "2" @default.
- W3015850939 countsByYear W30158509392022 @default.
- W3015850939 countsByYear W30158509392023 @default.
- W3015850939 crossrefType "journal-article" @default.
- W3015850939 hasAuthorship W3015850939A5001554332 @default.
- W3015850939 hasAuthorship W3015850939A5044570667 @default.
- W3015850939 hasAuthorship W3015850939A5049205349 @default.
- W3015850939 hasAuthorship W3015850939A5049923724 @default.
- W3015850939 hasAuthorship W3015850939A5057389827 @default.
- W3015850939 hasAuthorship W3015850939A5070298664 @default.
- W3015850939 hasConcept C126322002 @default.
- W3015850939 hasConcept C16005928 @default.
- W3015850939 hasConcept C197934379 @default.
- W3015850939 hasConcept C2776728111 @default.
- W3015850939 hasConcept C2777673923 @default.
- W3015850939 hasConcept C2779121184 @default.
- W3015850939 hasConcept C2779306117 @default.
- W3015850939 hasConcept C2779980618 @default.
- W3015850939 hasConcept C71924100 @default.
- W3015850939 hasConceptScore W3015850939C126322002 @default.
- W3015850939 hasConceptScore W3015850939C16005928 @default.
- W3015850939 hasConceptScore W3015850939C197934379 @default.
- W3015850939 hasConceptScore W3015850939C2776728111 @default.
- W3015850939 hasConceptScore W3015850939C2777673923 @default.
- W3015850939 hasConceptScore W3015850939C2779121184 @default.
- W3015850939 hasConceptScore W3015850939C2779306117 @default.
- W3015850939 hasConceptScore W3015850939C2779980618 @default.
- W3015850939 hasConceptScore W3015850939C71924100 @default.
- W3015850939 hasIssue "04" @default.
- W3015850939 hasLocation W30158509391 @default.
- W3015850939 hasLocation W30158509392 @default.
- W3015850939 hasOpenAccess W3015850939 @default.
- W3015850939 hasPrimaryLocation W30158509391 @default.
- W3015850939 hasRelatedWork W2027061043 @default.
- W3015850939 hasRelatedWork W2086446723 @default.
- W3015850939 hasRelatedWork W2123442071 @default.
- W3015850939 hasRelatedWork W23299981 @default.
- W3015850939 hasRelatedWork W2465168834 @default.
- W3015850939 hasRelatedWork W3092352500 @default.
- W3015850939 hasRelatedWork W3111678840 @default.
- W3015850939 hasRelatedWork W3166787263 @default.
- W3015850939 hasRelatedWork W4213443142 @default.
- W3015850939 hasRelatedWork W4318000910 @default.
- W3015850939 hasVolume "127" @default.
- W3015850939 isParatext "false" @default.
- W3015850939 isRetracted "false" @default.
- W3015850939 magId "3015850939" @default.
- W3015850939 workType "article" @default.